Report Detail
Global Active Pharmaceutical Ingredients CDMO Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4348661 |
- 20 October, 2021 |
- Global |
- 107 Pages |
- QYResearch |
- Other
contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
Market Insights
QY Research has lately published a report titled “Global Active Pharmaceutical Ingredients CDMO Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application”, with the help of industry-leading research methods, along with observing subtle details and understanding the overall dynamics.
The insights included in this report have been prepared in view of varied aspects that affect the growth. The report elucidates key drivers, trends, prospects, restraining factors, and challenges that players may across in the coming years. With the assistance of this research, players can recognize and capitalize on profitable opportunities. They can further utilize it to make the required advancements in their operations to acquire a competitive advantage over other participants.
The global Active Pharmaceutical Ingredients CDMO market size is projected to reach US$ million by 2027, from US$ million in 2020, at a CAGR of % during 2021-2027.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2016-2027. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Traditional Active Pharmaceutical Ingredient (Traditional API)
Highly Potent Active Pharmaceutical Ingredient (HP-API)
Antibody Drug Conjugate (ADC)
Others
Segment by Application
Oncology
Hormonal
Glaucoma
Cardiovascular
Diabetes
Others
Regional Scope
This segment of the report offers a thorough regional study of the global Active Pharmaceutical Ingredients CDMO market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2016-2027. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2016-2021. Following is the list of key manufacturers observed in this research study:
Cambrex
Recipharm
Thermo Fisher Pantheon
Corden Pharma
Samsung Biologics
Lonza
Catalent
Siegfried
Piramal Pharma Solutions
Boehringer Ingelheim
Frequently Asked Questions
Which application segment captured the leading share in the Active Pharmaceutical Ingredients CDMO market?
How fragmented is the Active Pharmaceutical Ingredients CDMO market?
Which are the key growth drivers in the Active Pharmaceutical Ingredients CDMO market?
Which are the top strategies undertaken by the Active Pharmaceutical Ingredients CDMO market players?
Which technological trends are likely to affect the Active Pharmaceutical Ingredients CDMO market?
What is the expected Active Pharmaceutical Ingredients CDMO market size by 2027?
Which companies are dominating the Active Pharmaceutical Ingredients CDMO market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Active Pharmaceutical Ingredients CDMO market growth?
Which are the emerging companies in the Active Pharmaceutical Ingredients CDMO market?
Table of Contents
1 Market Overview of Active Pharmaceutical Ingredients CDMO
- 1.1 Active Pharmaceutical Ingredients CDMO Market Overview
- 1.1.1 Active Pharmaceutical Ingredients CDMO Product Scope
- 1.1.2 Active Pharmaceutical Ingredients CDMO Market Status and Outlook
- 1.2 Global Active Pharmaceutical Ingredients CDMO Market Size Overview by Region 2016 VS 2021 VS 2027
- 1.3 Global Active Pharmaceutical Ingredients CDMO Market Size by Region (2016-2027)
- 1.4 Global Active Pharmaceutical Ingredients CDMO Historic Market Size by Region (2016-2021)
- 1.5 Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Region (2022-2027)
- 1.6 Key Regions, Active Pharmaceutical Ingredients CDMO Market Size (2016-2027)
- 1.6.1 North America Active Pharmaceutical Ingredients CDMO Market Size (2016-2027)
- 1.6.2 Europe Active Pharmaceutical Ingredients CDMO Market Size (2016-2027)
- 1.6.3 Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size (2016-2027)
- 1.6.4 Latin America Active Pharmaceutical Ingredients CDMO Market Size (2016-2027)
- 1.6.5 Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size (2016-2027)
2 Active Pharmaceutical Ingredients CDMO Market Overview by Type
- 2.1 Global Active Pharmaceutical Ingredients CDMO Market Size by Type: 2016 VS 2021 VS 2027
- 2.2 Global Active Pharmaceutical Ingredients CDMO Historic Market Size by Type (2016-2021)
- 2.3 Global Active Pharmaceutical Ingredients CDMO Forecasted Market Size by Type (2022-2027)
- 2.4 Traditional Active Pharmaceutical Ingredient (Traditional API)
- 2.5 Highly Potent Active Pharmaceutical Ingredient (HP-API)
- 2.6 Antibody Drug Conjugate (ADC)
- 2.7 Others
3 Active Pharmaceutical Ingredients CDMO Market Overview by Application
- 3.1 Global Active Pharmaceutical Ingredients CDMO Market Size by Application: 2016 VS 2021 VS 2027
- 3.2 Global Active Pharmaceutical Ingredients CDMO Historic Market Size by Application (2016-2021)
- 3.3 Global Active Pharmaceutical Ingredients CDMO Forecasted Market Size by Application (2022-2027)
- 3.4 Oncology
- 3.5 Hormonal
- 3.6 Glaucoma
- 3.7 Cardiovascular
- 3.8 Diabetes
- 3.9 Others
4 Active Pharmaceutical Ingredients CDMO Competition Analysis by Players
- 4.1 Global Active Pharmaceutical Ingredients CDMO Market Size by Players (2016-2021)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients CDMO as of 2020)
- 4.3 Date of Key Players Enter into Active Pharmaceutical Ingredients CDMO Market
- 4.4 Global Top Players Active Pharmaceutical Ingredients CDMO Headquarters and Area Served
- 4.5 Key Players Active Pharmaceutical Ingredients CDMO Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Active Pharmaceutical Ingredients CDMO Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 Cambrex
- 5.1.1 Cambrex Profile
- 5.1.2 Cambrex Main Business
- 5.1.3 Cambrex Active Pharmaceutical Ingredients CDMO Products, Services and Solutions
- 5.1.4 Cambrex Active Pharmaceutical Ingredients CDMO Revenue (US$ Million) & (2016-2021)
- 5.1.5 Cambrex Recent Developments
- 5.2 Recipharm
- 5.2.1 Recipharm Profile
- 5.2.2 Recipharm Main Business
- 5.2.3 Recipharm Active Pharmaceutical Ingredients CDMO Products, Services and Solutions
- 5.2.4 Recipharm Active Pharmaceutical Ingredients CDMO Revenue (US$ Million) & (2016-2021)
- 5.2.5 Recipharm Recent Developments
- 5.3 Thermo Fisher Pantheon
- 5.3.1 Thermo Fisher Pantheon Profile
- 5.3.2 Thermo Fisher Pantheon Main Business
- 5.3.3 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Products, Services and Solutions
- 5.3.4 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Revenue (US$ Million) & (2016-2021)
- 5.3.5 Corden Pharma Recent Developments
- 5.4 Corden Pharma
- 5.4.1 Corden Pharma Profile
- 5.4.2 Corden Pharma Main Business
- 5.4.3 Corden Pharma Active Pharmaceutical Ingredients CDMO Products, Services and Solutions
- 5.4.4 Corden Pharma Active Pharmaceutical Ingredients CDMO Revenue (US$ Million) & (2016-2021)
- 5.4.5 Corden Pharma Recent Developments
- 5.5 Samsung Biologics
- 5.5.1 Samsung Biologics Profile
- 5.5.2 Samsung Biologics Main Business
- 5.5.3 Samsung Biologics Active Pharmaceutical Ingredients CDMO Products, Services and Solutions
- 5.5.4 Samsung Biologics Active Pharmaceutical Ingredients CDMO Revenue (US$ Million) & (2016-2021)
- 5.5.5 Samsung Biologics Recent Developments
- 5.6 Lonza
- 5.6.1 Lonza Profile
- 5.6.2 Lonza Main Business
- 5.6.3 Lonza Active Pharmaceutical Ingredients CDMO Products, Services and Solutions
- 5.6.4 Lonza Active Pharmaceutical Ingredients CDMO Revenue (US$ Million) & (2016-2021)
- 5.6.5 Lonza Recent Developments
- 5.7 Catalent
- 5.7.1 Catalent Profile
- 5.7.2 Catalent Main Business
- 5.7.3 Catalent Active Pharmaceutical Ingredients CDMO Products, Services and Solutions
- 5.7.4 Catalent Active Pharmaceutical Ingredients CDMO Revenue (US$ Million) & (2016-2021)
- 5.7.5 Catalent Recent Developments
- 5.8 Siegfried
- 5.8.1 Siegfried Profile
- 5.8.2 Siegfried Main Business
- 5.8.3 Siegfried Active Pharmaceutical Ingredients CDMO Products, Services and Solutions
- 5.8.4 Siegfried Active Pharmaceutical Ingredients CDMO Revenue (US$ Million) & (2016-2021)
- 5.8.5 Siegfried Recent Developments
- 5.9 Piramal Pharma Solutions
- 5.9.1 Piramal Pharma Solutions Profile
- 5.9.2 Piramal Pharma Solutions Main Business
- 5.9.3 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Products, Services and Solutions
- 5.9.4 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Revenue (US$ Million) & (2016-2021)
- 5.9.5 Piramal Pharma Solutions Recent Developments
- 5.10 Boehringer Ingelheim
- 5.10.1 Boehringer Ingelheim Profile
- 5.10.2 Boehringer Ingelheim Main Business
- 5.10.3 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Products, Services and Solutions
- 5.10.4 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Revenue (US$ Million) & (2016-2021)
- 5.10.5 Boehringer Ingelheim Recent Developments
6 North America
- 6.1 North America Active Pharmaceutical Ingredients CDMO Market Size by Country (2016-2027)
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Active Pharmaceutical Ingredients CDMO Market Size by Country (2016-2027)
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size by Region (2016-2027)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America Active Pharmaceutical Ingredients CDMO Market Size by Country (2016-2027)
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Country (2016-2027)
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 Active Pharmaceutical Ingredients CDMO Market Dynamics
- 11.1 Active Pharmaceutical Ingredients CDMO Industry Trends
- 11.2 Active Pharmaceutical Ingredients CDMO Market Drivers
- 11.3 Active Pharmaceutical Ingredients CDMO Market Challenges
- 11.4 Active Pharmaceutical Ingredients CDMO Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on Active Pharmaceutical Ingredients CDMO. Industry analysis & Market Report on Active Pharmaceutical Ingredients CDMO is a syndicated market report, published as Global Active Pharmaceutical Ingredients CDMO Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Active Pharmaceutical Ingredients CDMO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
